These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35131442)

  • 1. Metabolomic and inflammatory signatures of symptom dimensions in major depression.
    Brydges CR; Bhattacharyya S; Dehkordi SM; Milaneschi Y; Penninx B; Jansen R; Kristal BS; Han X; Arnold M; Kastenmüller G; Bekhbat M; Mayberg HS; Craighead WE; Rush AJ; Fiehn O; Dunlop BW; Kaddurah-Daouk R;
    Brain Behav Immun; 2022 May; 102():42-52. PubMed ID: 35131442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression profilers and immuno-metabolic dysregulation: Longitudinal results from the NESDA study.
    Lamers F; Milaneschi Y; Vinkers CH; Schoevers RA; Giltay EJ; Penninx BWJH
    Brain Behav Immun; 2020 Aug; 88():174-183. PubMed ID: 32272220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic biosignature differentiates melancholic depressive patients from healthy controls.
    Liu Y; Yieh L; Yang T; Drinkenburg W; Peeters P; Steckler T; Narayan VA; Wittenberg G; Ye J
    BMC Genomics; 2016 Aug; 17(1):669. PubMed ID: 27549765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiome-Linked Metabolites in the Pathobiology of Major Depression With or Without Anxiety-A Role for Bile Acids.
    MahmoudianDehkordi S; Bhattacharyya S; Brydges CR; Jia W; Fiehn O; Rush AJ; Dunlop BW; Kaddurah-Daouk R
    Front Neurosci; 2022; 16():937906. PubMed ID: 35937867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic profiles discriminating anxiety from depression.
    de Kluiver H; Jansen R; Milaneschi Y; Bot M; Giltay EJ; Schoevers R; Penninx BWJH
    Acta Psychiatr Scand; 2021 Aug; 144(2):178-193. PubMed ID: 33914921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort.
    Montanari S; Jansen R; Schranner D; Kastenmüller G; Arnold M; Janiri D; Sani G; Bhattacharyya S; Dehkordi SM; Dunlop BW; Rush AJ; Penninx BWHJ; Kaddurah-Daouk R; Milaneschi Y
    medRxiv; 2024 Feb; ():. PubMed ID: 38405847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics dissection of depression heterogeneity and related cardiometabolic risk.
    Alshehri T; Mook-Kanamori DO; Willems van Dijk K; Dinga R; Penninx BWJH; Rosendaal FR; le Cessie S; Milaneschi Y
    Psychol Med; 2023 Jan; 53(1):248-257. PubMed ID: 34078486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials.
    Vreijling SR; Chin Fatt CR; Williams LM; Schatzberg AF; Usherwood T; Nemeroff CB; Rush AJ; Uher R; Aitchison KJ; Köhler-Forsberg O; Rietschel M; Trivedi MH; Jha MK; Penninx BWJH; Beekman ATF; Jansen R; Lamers F
    Br J Psychiatry; 2024 Mar; 224(3):89-97. PubMed ID: 38130122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between serum lipids and major depressive disorder: results from the Netherlands Study of Depression and Anxiety (NESDA).
    van Reedt Dortland AK; Giltay EJ; van Veen T; van Pelt J; Zitman FG; Penninx BW
    J Clin Psychiatry; 2010 Jun; 71(6):729-36. PubMed ID: 20021996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot Study of Metabolomic Clusters as State Markers of Major Depression and Outcomes to CBT Treatment.
    Bhattacharyya S; Dunlop BW; Mahmoudiandehkordi S; Ahmed AT; Louie G; Frye MA; Weinshilboum RM; Krishnan RR; Rush AJ; Mayberg HS; Craighead WE; Kaddurah-Daouk R
    Front Neurosci; 2019; 13():926. PubMed ID: 31572108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between plasma tryptophan catabolites and depression: The role of symptom profiles and inflammation.
    Milaneschi Y; Allers KA; Beekman ATF; Giltay EJ; Keller S; Schoevers RA; Süssmuth SD; Niessen HG; Penninx BWJH
    Brain Behav Immun; 2021 Oct; 97():167-175. PubMed ID: 34252568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic profiles of 38 acylcarnitines in major depressive episodes before and after treatment.
    Ait Tayeb AEK; Colle R; Chappell K; El-Asmar K; Acquaviva-Bourdain C; David DJ; Trabado S; Chanson P; Feve B; Becquemont L; Verstuyft C; Corruble E
    Psychol Med; 2024 Jan; 54(2):289-298. PubMed ID: 37226550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between clinical and biological characteristics of depression and structural brain alterations.
    Toenders YJ; Schmaal L; Nawijn L; Han LKM; Binnewies J; van der Wee NJA; van Tol MJ; Veltman DJ; Milaneschi Y; Lamers F; Penninx BWJH
    J Affect Disord; 2022 Sep; 312():268-274. PubMed ID: 35760189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D.
    Fava M; Alpert JE; Carmin CN; Wisniewski SR; Trivedi MH; Biggs MM; Shores-Wilson K; Morgan D; Schwartz T; Balasubramani GK; Rush AJ
    Psychol Med; 2004 Oct; 34(7):1299-308. PubMed ID: 15697056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-α, IL-6 and hsCRP in patients with melancholic, atypical and anxious depression: an antibody array analysis related to somatic symptoms.
    Liu H; Wu X; Wang Y; Liu X; Peng D; Wu Y; Chen J; Su Y; Xu J; Ma X; Li Y; Shi J; Yang X; Rong H; Forti MD; Fang Y
    Gen Psychiatr; 2022; 35(4):e100844. PubMed ID: 36189181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of anxious distress in immune dysregulation in patients with major depressive disorder.
    Gaspersz R; Lamers F; Wittenberg G; Beekman ATF; van Hemert AM; Schoevers RA; Penninx BWJH
    Transl Psychiatry; 2017 Dec; 7(12):1268. PubMed ID: 29217840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning.
    Sánchez-Carro Y; de la Torre-Luque A; Leal-Leturia I; Salvat-Pujol N; Massaneda C; de Arriba-Arnau A; Urretavizcaya M; Pérez-Solà V; Toll A; Martínez-Ruiz A; Ferreirós-Martínez R; Pérez S; Sastre J; Álvarez P; Soria V; López-García P
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar; 121():110674. PubMed ID: 36332700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes.
    Ahmed AT; MahmoudianDehkordi S; Bhattacharyya S; Arnold M; Liu D; Neavin D; Moseley MA; Thompson JW; Williams LSJ; Louie G; Skime MK; Wang L; Riva-Posse P; McDonald WM; Bobo WV; Craighead WE; Krishnan R; Weinshilboum RM; Dunlop BW; Millington DS; Rush AJ; Frye MA; Kaddurah-Daouk R;
    J Affect Disord; 2020 Mar; 264():90-97. PubMed ID: 32056779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melancholic and atypical major depression--connection between cytokines, psychopathology and treatment.
    Dunjic-Kostic B; Ivkovic M; Radonjic NV; Petronijevic ND; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Jasovic-Gasic M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():1-6. PubMed ID: 23200828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort.
    Milaneschi Y; Montanari S; Jansen R; Schranner D; Kastenmüller G; Arnold M; Janiri D; Sani G; Bhattacharyya S; Dehkordi SM; Dunlop B; Rush A; Penninx B; Kaddurah-Daouk R
    Res Sq; 2024 Aug; ():. PubMed ID: 39149483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.